The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patients.

about

The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patients.

Item

http://www.wikidata.org/entity/Q42285086

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The relationship of plasma ADM ...... peritoneal dialysis patients.

@en

The relationship of plasma ADM ...... peritoneal dialysis patients.

@nl

type

Item

label

The relationship of plasma ADM ...... peritoneal dialysis patients.

@en

The relationship of plasma ADM ...... peritoneal dialysis patients.

@nl

prefLabel

The relationship of plasma ADM ...... peritoneal dialysis patients.

@en

The relationship of plasma ADM ...... peritoneal dialysis patients.

@nl

P1476

The relationship of plasma ADM ...... peritoneal dialysis patients.

@en

P2093

Ahmet Gurdal

http://www.w3.org/2001/XMLSchema#string

Baki Kumbasar

http://www.w3.org/2001/XMLSchema#string

Macit Koldas

http://www.w3.org/2001/XMLSchema#string

Meltem Gursu

http://www.w3.org/2001/XMLSchema#string

Metin Yegen

http://www.w3.org/2001/XMLSchema#string

Rumeyza Kazancioglu

http://www.w3.org/2001/XMLSchema#string

Sami Uzun

http://www.w3.org/2001/XMLSchema#string

Savas Ozturk

http://www.w3.org/2001/XMLSchema#string

Serhat Karadag

http://www.w3.org/2001/XMLSchema#string

Zeki Aydin

http://www.w3.org/2001/XMLSchema#string

P2860

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.

Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?

Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.

Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.

Novel cardiovascular risk factors in end-stage renal disease.

ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction.

Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients.

P2888

s10157-012-0739-7

P304

431-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10157-012-0739-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23183784

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis